Skip to content

A study to assess the relationship between blood glucose control and self-management activities including diet, exercise, sleep, medication consumption and other daily routines for individuals with type 2 diabetes.

PROSPECTIVE COHORT STUDY OF FACTORS INFLUENCING GLUCOSE CONTROL AMONG INDIANS WITH TYPE 2 DIABETES

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/040619
Enrollment
1550
Registered
2022-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Decipher Health Inc
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age more or equal to 18 and less than 75 years 2.Physician-diagnosed type 2 diabetes treated with not more than or equal to 1 oral hypoglycemic agent concurrent treatment with an injectable non-insulin agent is permitted 3.Hemoglobin A1c HbA1c not more than or equal to 7.0 Percent recorded within the past 30 days. 4. Mobile phone capable of running the protocol-specific applications. 5.Functional English literacy

Exclusion criteria

Exclusion criteria: 1.Unable or unwilling to provide informed consent 2.Unable operate or use the protocol-specified devices and applications or to comply with the study-specified procedures (including food allergies) 3. Unable to fast from midnight the night before the initial study visit 4. Current use of prandial insulin including a continuous insulin infusion pump (basil insulin use alone is permitted) 5. Currently pregnant or planning to become pregnant 6.Estimated life expectancy 7. Active cancer 8. Myocardial infarction or stroke in the last 6 months 9. Receiving or planned to initiate dialysis for end-stage renal disease 10. Receiving oral or intravenous steroids 11. Any contraindication to using a continuous glucose monitor (CGM)

Design outcomes

Primary

MeasureTime frame
The primary outcome for the study is postprandial glycemic response (PPGR). Following the Wolever and Jenkins method and logged mealtimes and continuous glucose measurements will be used to calculate the incremental area under the curve (iAUC). Timepoint: Approximately 4 weeks or 29 days

Secondary

MeasureTime frame
Not availableTimepoint: Not available

Countries

India

Contacts

Public ContactJaganath Swamy

Deciphering Health India Private Limited

science@decipherhealth.com9711197847

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026